The cannabis industry is receiving a massive push with the help of changes to state laws and studies that uncover the secrets of the naturally occurring beneficial compound, cannabidiol (CBD). Research firms are putting the compound into the limelight of their studies, and this could help support both industries in the long run as there will be more reasons for agencies to reconsider their stand on cannabis.
Norfolk-based Sanyal Biotechnology acquired licensing to import CBD for research and clinical trials last May after receiving encouragement from Ontario-based Revive Therapeutics. With the license secure, the company is planning to uncover CBD’s potential in curing obesity and non-alcoholic steatohepatities (NASH), which is a serious case of non-alcoholic fatty liver disease.
Sanyal CEO Rebecca Caffrey says that they never expected to become a part of the industry. She adds that the licensing process with the Virginia Board of Pharmacy and the U.S. Drug Enforcement Agency took a year. It was almost impossible to get a license, she adds, so they opted to get the broadest license available instead.
The final key to unlock cannabis’ potential
The industry needs more studies to back the claims made by many regarding the compound’s benefits. Although it is a far cry from marijuana, CBD is still widely regarded as a controlled substance. In fact, the U.S. Drug Enforcement Administration only recently reclassified the drug into a Schedule 5 substance.
Uncovering the secrets of CBD is also the key to realizing its full potential. There are many individuals who could use the compound in their lives. For instance, athletes can use the compound to relieve themselves of pain. There are also claims that CBD can be used to treat PTSD in veterans.
Another leader in the research and development of CBD
The good thing is that more companies are being drawn into the research and development of CBD. PotNetwork Holdings, Inc. (OTCMKTS:POTN) has been in the industry long enough to know what the general audience wants, and it uses this knowledge to achieve milestones through its subsidiary and distributor, Diamond CBD, Inc.
To meet the demand for quality CBD products, POTN employs the aid of industry professionals and medical experts. This results in amazing products extracted from premium-quality hemp through supercritical CO2 extraction. As it moves forward with its research and development of CBD, POTN will be able to further increase its already expansive line of CBD products.
Diamond CBD’s products are a top choice among consumers. During the World Vapor Expo Industry Showcase at Mana Wynwood in Miami, Florida, the brand was able to draw the attention of countless vape enthusiasts. Part of the company’s product line is vape additives so their presence at the event was well-received since there is also a strong demand for CBD in Florida.
The CBD industry is becoming a success partially because of the companies that dive deep into the potential compound offers. The success of these companies’ research can result in a better understanding of the compound and this is direly needed as other major agencies are to reconsider their view on marijuana.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
BB Biotech: Positive development in a volatile market environment
The total shareholder return in 2020 was 19.3% in CHF and 18.1% in EUR, slightly below the performance of the...
Bitcoin slips back to $53,000 and major altcoins go lower on February 22nd
The fall seen in the price of Bitcoin on February 22 was also strongly felt among exponents such as Ethereum...
The keys to ESG investment in 2021 in the face of growing interest and profitability
While all the data point to the fact that investment under climate, social and corporate governance criteria is increasingly in...
New investments in the Fez-Meknes Region
As part of the industrial revival strategy, the Fez-Meknes Region should welcome 95 potential projects identified in the project bank....
Rebound in pharma and healthcare operations: 14% increase in 2020
The volume of mergers and acquisitions in the pharmaceutical and healthcare sector increased by 25% compared to the first half...
Cannabis6 days ago
The ANMAT will allow the importation of cannabis-based products in Argentina
Featured7 days ago
Banca Progetto prepares to launch instant lending for consumer credit
Featured7 days ago
Repsol hires Linklaters and Uría to list its renewable energy subsidiary
Crypto6 days ago
How LODEpay’s Price Oracle is Tackling Silver Spot Price Manipulation